Develop New Drugs to Disable Cancer Cell Defenses in Russia
Researcher Boris Gladkikh from Volgograd Technical University reveals ongoing efforts to develop new pharmaceutical compounds aimed at inhibiting the defense systems of cancer cells, making them more susceptible to traditional treatments. This innovation comes at a time when cancer cases are on the rise globally.